We study metabolites from a variety of environments and characterize novel bioactive compounds from Fiji, Vanuatu. These bioactive secondary metabolites can become lead compounds that target genes or proteins that causes diseases in the drug discovery process.
We study metabolites from a variety of environments and characterize novel bioactive compounds from Fiji, Vanuatu. These bioactive secondary metabolites can become lead compounds that target genes or proteins that causes diseases in the drug discovery process.